Matriptase is overexpressed in malignant mesothelioma and may be blocked by matriptase inhibitors leading to decreased cell invasion

被引：0
|
作者：
Frizelle, S
Ma, P
Salgia, R
Kumar, P
Hoang, C
Kratzke, R
机构：
[1] Minneapolis VA Med Ctr, Res Serv, Minneapolis, MN USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Univ Minnesota, Div Hemonc Treatment, Minneapolis, MN USA
[4] Univ Minnesota, Div Cardiovasc Surg, Minneapolis, MN USA
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80891-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [31] Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro
    Bjornland, K
    Buo, L
    Kjonniksen, I
    Larsen, M
    Fodstad, O
    Johansen, HT
    Aasen, AO
    ANTICANCER RESEARCH, 1996, 16 (4A) : 1627 - 1631
  • [32] Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase
    Cheng-Fan Lee
    Andrew Dang
    Elizabeth Hernandez
    Rey-Chen Pong
    Benjamin Chen
    Rajni Sonavane
    Ganesh Raj
    Payal Kapur
    Hsin-Ying Lin
    Shang-Ru Wu
    Chun-Jung Ko
    U-Ging Lo
    Hsin-yu Lee
    Jer-Tsong Hsieh
    Ming-Shyue Lee
    Oncogene, 2019, 38 : 5580 - 5598
  • [33] Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis
    Lin, Hsin-Ying
    Ko, Chun-Jung
    Lo, Tzu-Yu
    Wu, Shang-Ru
    Lan, Shao-Wei
    Huang, Chen-An
    Lin, Yi-Chin
    Lin, Hsin-Hsien
    Tu, Hsin-Fang
    Lee, Cheng-Fan
    Hsiao, Pei-Wen
    Huang, Hsiang-Po
    Chen, Mei-Jou
    Chang, Kai-Hsiung
    Lee, Ming-Shyue
    ONCOGENE, 2022, 41 (20) : 2833 - 2845
  • [34] Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis
    Hsin-Ying Lin
    Chun-Jung Ko
    Tzu-Yu Lo
    Shang-Ru Wu
    Shao-Wei Lan
    Chen-An Huang
    Yi-Chin Lin
    Hsin-Hsien Lin
    Hsin-Fang Tu
    Cheng-Fan Lee
    Pei-Wen Hsiao
    Hsiang-Po Huang
    Mei-Jou Chen
    Kai-Hsiung Chang
    Ming-Shyue Lee
    Oncogene, 2022, 41 : 2833 - 2845
  • [35] Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis
    K U Sales
    S Friis
    J E Konkel
    S Godiksen
    M Hatakeyama
    K K Hansen
    S R Rogatto
    R Szabo
    L K Vogel
    W Chen
    J S Gutkind
    T H Bugge
    Oncogene, 2015, 34 : 346 - 356
  • [36] Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis
    Sales, K. U.
    Friis, S.
    Konkel, J. E.
    Godiksen, S.
    Hatakeyama, M.
    Hansen, K. K.
    Rogatto, S. R.
    Szabo, R.
    Vogel, L. K.
    Chen, W.
    Gutkind, J. S.
    Bugge, T. H.
    ONCOGENE, 2015, 34 (03) : 288 - 298
  • [37] Arf6-AMAP1 pathway in invasion of lung cancer and malignant mesothelioma cell lines
    Menju, T.
    Hashimoto, S.
    Hashimoto, A.
    Ogawa, E.
    Wada, H.
    Date, H.
    Sabe, H.
    EJC SUPPLEMENTS, 2008, 6 (12): : 55 - 55
  • [38] Investigation of tumor suppressive effects of novel TEAD inhibitors on malignant mesothelioma cell lines.
    Akao, Ken
    Sato, Tatsuhiro
    Mukai, Satomi
    Hirano, Masaki
    Sekido, Yoshitaka
    CANCER SCIENCE, 2023, 114 : 1492 - 1492
  • [39] Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitro
    Porta, C
    Danova, M
    Orengo, AM
    Ferrini, S
    Moroni, M
    Gaggero, A
    Libener, R
    Betta, PG
    Ferrari, S
    Procopio, A
    Strizzi, L
    Mutti, L
    JOURNAL OF CELLULAR PHYSIOLOGY, 2000, 185 (01) : 126 - 134
  • [40] The Effect of Imiquimod on Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Malignant Melanoma Cell Invasion
    Jung, Jin Young
    Kim, Hyun Sook
    Roh, Mi Ryung
    Roh, Hyo Jin
    Lee, Sang Yoon
    Chung, Kee Yang
    ANNALS OF DERMATOLOGY, 2014, 26 (03) : 363 - 373
12345